Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 3.01 · 8-K

SKYX Platforms Corp.

SKYXNASDAQEQUITYCurrent

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 26, 2026, Efrat L. Greenstein Brayer, an independent member of the Board of Directors (the “Board”) of SKYX Platforms Corp. (the “Company”), passed away. Ms.…

Filed Oct 1, 2026Accepted Oct 1, 2026, 5:15 PM EDTCIK 1598981Accession 0001493152-26-045379
Share

Company context

Current securities

Historical securities (2)

Recent company filings

  1. Results of Operations and Financial ConditionNov 13, 2026
  2. 10-Q filingNov 12, 2026
  3. EFFECT filingOct 20, 2026
  4. S-3 filingOct 14, 2026
  5. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity SecuritiesOct 14, 2026

Registered securities in this filing

SKYX PLATFORMS CORP. · 8-K · Filed 2026-10-01

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, no par value per share

Symbol
SKYX
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: AsOf2026-09-28

Dimensions: Not supplied

Accession 000149315226045379 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 3.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 3.01Item 3.01 - Notice of Delisting
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 26, 2026, Efrat L. Greenstein Brayer, an independent member of the Board of Directors (the “Board”) of SKYX Platforms Corp. (the “Company”), passed away. Ms. Greenstein Brayer was a member of the audit committee and the compensation committee and the chair of the nominating and corporate governance committee of the Board. Ms. Greenstein Brayer was a highly respected member of the Board, and the Board and management are deeply saddened by her passing. On September 28, 2026, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that, due to Ms. Greenstein Brayer’s passing, the Company was no longer in compliance with Nasdaq Listing Rule 5605(b)(1), requiring that a majority of the Company’s Board consist of independent directors, and Nasdaq Listing Rule 5605(c)(2)(A), requiring that the Company’s audit committee consist of at least three members. On September 30, 2026, the Company received a letter from Nasdaq notifying the Company of the available cure period. Pursuant to Nasdaq Listing Rule 5605(b)(1)(A) and 5605(c)(4)(B), the Company is entitled to a cure period to regain compliance with Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2)(A), which cure period will expire upon the earlier of the Company’s next annual meeting of stockholders or September 26, 2027; provided, however, that if the next annual meeting of stockholders is held before March 25, 2027, then the Company must evidence compliance no later than March 25, 2027. The Company intends to take sufficient actions to regain compliance with the foregoing Nasdaq governance requirements on or before the expiration of the applicable cure periods provided in the Nasdaq Listing Rules. However, there can be no assurance that Company will be able to regain compliance with the applicable Nasdaq Listing Rules set forth above within the required cure period. The foregoing has no immediate effect on the Company’s Nasdaq listing, subject to compliance with the listing rules.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.